Kuo, Be-Sheng
5083  results:
Search for persons X
?
 
?
 
?
5

The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl..:

Hu, Lain-Yen ; Ryder, Todd R. ; Rafferty, Michael F....
Bioorganic & Medicinal Chemistry.  8 (2000)  6 - p. 1203-1212 , 2000
 
?
6

Sample pooling to enhance throughput of brain penetration s..:

Atherton, James P ; Van Noord, Ted J ; Kuo, Be-Sheng
Journal of Pharmaceutical and Biomedical Analysis.  20 (1999)  1-2 - p. 39-47 , 1999
 
?
7

Sample pooling to expedite bioanalysis and pharmacokinetic ..:

Kuo, Be-Sheng ; Van Noord, Ted ; Feng, M.Rose.
Journal of Pharmaceutical and Biomedical Analysis.  16 (1998)  5 - p. 837-846 , 1998
 
?
 
?
9

The tachykinin NK1 receptor antagonist PD 154075 blocks cis..:

Singh, Lakhbir ; Field, Mark J ; Hughes, John...
European Journal of Pharmacology.  321 (1997)  2 - p. 209-216 , 1997
 
?
10

Development of HPLC plasma assays for CAM 4515 and CAM 4750..:

Van Noord, Ted ; Scott Wright, D. ; Kuo, Be-Sheng
Journal of Pharmaceutical and Biomedical Analysis.  14 (1996)  12 - p. 1709-1716 , 1996
 
?
11

Absorption of Cam-2445, an NK1 Neurokinin Receptor Antagoni..:

Helen Chan, O. ; Schmid, Heidi L. ; Kuo, Be-Sheng...
Journal of Pharmaceutical Sciences.  85 (1996)  3 - p. 253-257 , 1996
 
?
13

Considerations in the development of a sensitive HPLC assay..:

Kagel, John R. ; Rossi, David T. ; Nordblom, Gerald D....
Journal of Pharmaceutical and Biomedical Analysis.  13 (1995)  10 - p. 1205-1213 , 1995
 
?
14

Determination of Bioavailability and Systemically Available..:

Kuo, Be-Sheng ; Poole, James C. ; Hwang, Kin-Kai.
Journal of Pharmaceutical Sciences.  83 (1994)  3 - p. 386-390 , 1994
 
1-15